Scilex Holding (SCLXW) Change in Cash (2020 - 2026)
Scilex Holding (SCLXW) recorded quarterly Change in Cash of -$1.6 million in Q1 2026, down 139.34% quarter-over-quarter from $4.1 million in Q4 2025, and down 163.45% on a YoY basis from $2.5 million in Q1 2025.
Scilex Holding (SCLXW) Change in Cash (2020 - 2026) Analysis & Trends
Scilex Holding's Change in Cash history runs 7 years deep, the most recent figure standing at -$1.6 million for Q1 2026.
- In Q1 2026, Change in Cash fell 163.45% year-over-year to -$1.6 million; the TTM figure through Mar 2026 stood at -$2.4 million (down 180.93% YoY), while the FY2025 annual figure was $1.7 million, up 215.51% from the prior year.
- Change in Cash was -$1.6 million for Q1 2026 at Scilex Holding, down from $4.1 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $30.1 million in Q2 2023 to a low of -$33.1 million in Q3 2023.
- Historically, Change in Cash has averaged -$58058.8 across 5 years, with a median of -$1.5 million in 2024.
- Biggest YoY gain for Change in Cash was 10177.14% in 2022; the steepest drop was 11874.91% in 2022.
- A 5-year view of Change in Cash shows it stood at -$299000.0 in 2022, then surged by 1019.4% to $2.7 million in 2023, then slumped by 276.21% to -$4.8 million in 2024, then jumped by 184.17% to $4.1 million in 2025, then sank by 139.34% to -$1.6 million in 2026.
- The last three Change in Cash figures came in at -$1.6 million (Q1 2026), $4.1 million (Q4 2025), and -$3.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -71.45 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | -1.99 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 1.98 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 4.16 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | -9.29 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 2.91 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 65.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 563.00 Mn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | -635.00 Mn |
| 10 | Scilex Holding | - | - | 4.15 Mn | -1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.60 Mn |
| Dec 31, 2025 | 4.08 Mn |
| Sep 30, 2025 | -3.22 Mn |
| Jun 30, 2025 | -1.70 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | -4.84 Mn |
| Sep 30, 2024 | -1.55 Mn |
| Jun 30, 2024 | 6.89 Mn |
| Mar 31, 2024 | -1.96 Mn |
| Dec 31, 2023 | 2.75 Mn |
| Sep 30, 2023 | -33.15 Mn |
| Jun 30, 2023 | 30.06 Mn |
| Mar 31, 2023 | 2.89 Mn |
| Dec 31, 2022 | -299,000.00 |
| Sep 30, 2022 | -4.34 Mn |
| Jun 30, 2022 | -26.74 Mn |
| Mar 31, 2022 | 29.23 Mn |
| Dec 31, 2021 | -586,131.00 |
| Sep 30, 2021 | -426,387.00 |
| Jun 30, 2021 | 227,110.00 |